Month: May 2022

RNS ANNOUCEMENT FORESIGHT ENTERPRISE VCT PLC (Company)Legal Entity Identity number: 213800MWJNR3WZZ3ZP42Supplementary Prospectus The board of the Company (Board) announce that it has published a supplementary prospectus (Supplementary Prospectus) relating to the offer for subscription to raise up to £20 million (with an over-allotment facility to raise up to a further £10 million) through the issue of new shares (Offer). The Supplementary Prospectus refers to the publication of the Company’s annual report and accounts for the year ended 31 December 2021 (2021 Accounts), certain information from which is incorporated by reference into the Supplementary Prospectus. Copies of the Supplementary Prospectus and the 2021 Accounts have been submitted to the Financial Conduct Authority and will shortly be available for inspection at the National...

FORT WORTH, Texas, May 20, 2022 (GLOBE NEWSWIRE) — TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing (TFF) technology platform, today announced that President and CEO Glenn Mattes will be virtually participating in the H.C. Wainwright Global Investment Conference being held May 23 – 26, 2022. Company management will also be participating in virtual one-on-one meetings throughout the conference.H.C. Wainwright Global Investment Conference   Presentation: Presentation available Tuesday, May 24, 2022 at 7:00 am ET   Presenter: Glenn Mattes, President and Chief Executive Officer   Webcast: https://journey.ct.events/view/5f089b49-225b-422b-aaa9-86eec6c06b4aPlease...

DUBLIN, Ireland, May 20, 2022 (GLOBE NEWSWIRE) — Trinity Biotech plc (Nasdaq: TRIB) has achieved a CE Mark for its 10-minute Covid-19 antigen test. This CE mark allows for use by healthcare professionals and trained users. The Company intends to launch the test throughout the European Union as well as other countries that recognise the CE Mark designation. In addition to its ease-of-use and impressive speed to result, in extensive clinical trails the test has demonstrated excellent 99% sensitivity and 99% specificity which are accuracy levels superior to many of the tests currently on the market. The test uses an anterior nasal swab sample rather than the more invasive nasopharangeal swab, providing a more comfortable patient experience. The test also has several features that benefit the user including a convenient pre-filled...

RIO DE JANEIRO, Brazil, May 20, 2022 (GLOBE NEWSWIRE) — Vinci Partners Investments Ltd. (NASDAQ: VINP) (“Vinci Partners”, “we”, “the Company”, “us” or “our”), the controlling company of a leading alternative investment platform in Brazil, aligned with its continuous efforts towards governance’s best practices, announced today the release of its annual Environmental, Social & Governance (“ESG”) report. This is the first ESG Report written by Vinci Partners, referring to the year 2021. The document was prepared based on Global Reporting Initiative (GRI) standards, in the Essential option, and follows the best practices of transparency, management and information disclosure to the market. “Among the important actions on this issue, I highlight the establishment of the ‘ESG Forum – Vinci’s Invested Companies’ to bring...

LEXINGTON, Mass., May 20, 2022 (GLOBE NEWSWIRE) — T2 Biosystems, Inc. (NASDAQ:TTOO) a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, announced today the U.S. Patent and Trademark Office has issued patent number 11,326,213 (the ‘213 Patent), “NMR Methods and Systems for the Rapid Detection of Tick-Borne Pathogens”. The ‘213 Patent covers the T2Lyme™ Panel, which identifies the bacteria that cause Lyme disease directly from a patient’s blood in 3 to 5 hours. The T2Lyme Panel runs on the T2Dx Instrument®, the same instrument currently used to run the FDA-cleared T2Bacteria® and T2Candida® Panels. Lyme disease is a debilitating disease caused by the bacteria Borrelia burgdorferi and is transmitted to humans through the bite of infected ticks. Typical symptoms include fever, headache, fatigue...

CARLSBAD, Calif., May 20, 2022 (GLOBE NEWSWIRE) — Qualigen Therapeutics, Inc. (Nasdaq: QLGN), a diversified life sciences company focused on developing treatments for adult and pediatric cancers with potential for Orphan Drug Designation, while also commercializing diagnostics, today announces that Qualigen Therapeutics Management will present a corporate overview during the H.C. Wainwright Global Investment Conference. The conference is being held on May 23 – 26, 2022 at the Fontainebleau Hotel in Miami Beach, FL and virtually. The presentation will provide an overview of the company’s oncology drug pipeline and recent developments in its diagnostics business. Presentation Webcast Details:Webcast Link: www.qualigeninc.com/hcw22 Viewable starting 7:00 AM ET, Tuesday, May 24, 2022 Viewable for 90 days following conferenceManagement...

Wyoming, USA, May 20, 2022 (GLOBE NEWSWIRE) — Protect Pharmaceutical Corporation, Inc. “OTC:(PRTT)” announces that after many months of strategic planning and development, the two companies are ready to announce the details of their upcoming merger. Protect Pharmaceutical Corporation, Inc. will enter into a share exchange agreement with Aetsoft (a leading blockchain solutions provider in EU region www.aetsoft.net) in order to secure its strategic goals for the web 3.0 market. The agreement is to acquire 100% of the outstanding shares of Aetsoft. Aetsoft has an extremely strong development and management team that will bring instant significant value to PRTT. The deal will drive PRTT’s position as an emerging tech innovation company and allow the consolidation of financial flows required to develop and launch the its premier products...

Iconic Burger Chain Grows Casino Locations with First Location on Las Vegas Strip LOS ANGELES, May 20, 2022 (GLOBE NEWSWIRE) — FAT (Fresh. Authentic. Tasty.) Brands Inc., parent company of Fatburger, is pleased to announce that Fatburger has officially opened in the Excalibur Hotel & Casino. The location marks the third casino location to date in Las Vegas, joining Red Rock Casino and Santa Fe Station. Hollywood’s favorite burger will also be arriving at The Venetian® Resort Las Vegas this summer. “We have seen great success with Fatburger locations in casinos over the years and are thrilled to expand upon that by opening at two iconic properties right on the Las Vegas Strip,” said Jake Berchtold, COO of FAT Brands’ Fast Casual Division. “Whether you are looking for a quick dinner before catching a show or a late-night burger...